Topic archive

johnson & johnson

2 stories

11/13/2026

HHS commits $25M to ibogaine and other psychotropic drugs

Investment aims to advance treatments for PTSD and substance use disorders.

8/21/2026

Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.